Commentary

A new report just uncovered millions of dollars in Medicare waste. The report, from the Office of the Inspector General at the Centers for Medicare and Medicaid Services, found that the agency paid for some of the same drugs twice, wasting $160 million. Unfortunately, this is only...

The Trump administration is conducting a search for a replacement for Dr. Scott Gottlieb, who resigned as head of the Food and Drug Administration in March. The position is one of the most important in the federal government, because the FDA is ubiquitous in Americans’...

Sen. Elizabeth Warren, with one eye on California presidential primary votes and the other on the state’s rich political donors, recently wrote an op-ed in the Sacramento Bee in which she demanded someone do something about that “shameful” gig economy. Warren, a Rutgers-trained lawyer, has expended...

When it comes to determining value, the U.S. health care system faces unique challenges. Without a better approach, the twin goals of continued innovation and broad-based drug affordability will be difficult, if not impossible, to maintain. Value assessment models are quickly becoming the approach du jour to overcome...

Much of the medical progress in the past half-century has involved expensive, high-tech diagnostic tests and therapies. But it would be a mistake to gainsay the value of inexpensive, low-tech innovations. Consider the problem of falls, which are both a cause and effect of declining health...

Infectious diseases that used to claim the lives of 1-in-6 children before their fifth year are making an alarming comeback in the United States. The culprits are parents who should know better—and the politicians who accommodate them. Parents of small children today no longer know the...